Page last updated: 2024-07-31 17:05:02

taxifolin-3-glucopyranoside

Description

taxifolin-3-glucopyranoside: from root-sprouts of Agrimonia pilosa Ledeb; structure given in first source [MeSH]

Cross-References

ID SourceID
PubMed CID3035567
CHEMBL ID2332679
MeSH IDM0184153

Synonyms (13)

Synonym
taxifolin-3-glucopyranoside
(2s,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
taxifolin-3-o-beta-d-glucopyranoside
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-d-glucopyranosyloxy)-2,3-dihydro-5,7-dihydroxy-, (2s-trans)-
(2s-trans)-2-(3,4-dihydroxyphenyl)-3-(beta-d-glucopyranosyloxy)-2,3-dihydro-5,7-dihydroxy-4h-1-benzopyran-4-one
129212-92-6
taxifolin-3'-o-beta-d-pyranglucoside
CHEMBL2332679
(2s,3s)-(-)-glucodistylin
DTXSID40156095
AKOS032948806
STARBLD0000802
FS-10287

Bioassays (3)

Assay IDTitleYearJournalArticle
AID735838Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 20 ug/ml after 24 hrs by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
ISSN: 1520-6025
Antioxidant lignans and chromone glycosides from Eurya japonica.
AID735839Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs at 20 ug/ml2013Journal of natural products, Apr-26, Volume: 76, Issue:4
ISSN: 1520-6025
Antioxidant lignans and chromone glycosides from Eurya japonica.
AID735840Antioxidant activity assessed as DPPH radical scavenging activity by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
ISSN: 1520-6025
Antioxidant lignans and chromone glycosides from Eurya japonica.

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
d-alpha tocopherolalpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
2013201311.0low000010
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
2013201311.0low000010
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
2013201311.0low000010
lyonisidebeta-D-glucoside;
monosaccharide derivative;
steroid saponin
plant metabolite2013201311.0low000010
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranosidearomatic ether;
benzyl alcohols;
beta-D-glucoside;
monosaccharide derivative;
primary alcohol
antineoplastic agent;
metabolite
2013201311.0high000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cysteamineamine;
thiol
geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
2010201014.0low000100
catechincatechinantioxidant;
plant metabolite
2011201113.0low000010
3-hydroxyflavoneflavonols;
monohydroxyflavone
2004200420.0low000100
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1990201120.6medium001310
procyanidinproanthocyanidin2011201113.0low000010
astilbin3'-hydroxyflavanones;
4'-hydroxyflavanones;
alpha-L-rhamnoside;
flavanone glycoside;
monosaccharide derivative;
tetrahydroxyflavanone
anti-inflammatory agent;
plant metabolite;
radical scavenger
2004200420.0low000100
procyanidin b3biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin
anti-inflammatory agent;
antioxidant;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
metabolite
2011201113.0low000010
arabinoseL-arabinoseEscherichia coli metabolite;
mouse metabolite
2011201113.0low000010
taxifolintaxifolinmetabolite2011201113.0low000010
cytellin1990199034.0low001000
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
1990201120.6medium001310
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
2011201113.0low000010
lyoniside1990199034.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Dermatitis, Atopic02010201014.0high000100
Disease Models, Animal02010201014.0high000100
Eczema, Atopic02010201014.0high000100